INS and chronic kidney disease: In the subgroup analyses based on age, insulin use, chronic kidney disease, heart failure, duration of diabetes, and cardiovascular risks, the results followed the same overall trend, and no significant interactions were observed (all P-values for interaction > 0.05, Additional file 1: Table S4).